Why is Jubilant Pharmo falling/rising?

As of 14-Aug, Jubilant Pharmova Ltd is experiencing a decline in its stock price, currently at Rs 1,049.20, which reflects a decrease of Rs 30.4 or 2.82%. Today's price summary indicates that the stock has underperformed its sector by 2.94%, touching an intraday low of Rs 1,049. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 21.84% against the 5-day average. Despite these challenges, the company has shown positive results over the last eight consecutive quarters, with a significant growth in profit after tax and a low debt-equity ratio, indicating a strong financial position.
In the broader market context, the stock has underperformed relative to the Sensex, with a 1-week return of -5.94% compared to a negligible change of -0.03% for the benchmark. Over the past month, Jubilant Pharmova has seen a decline of 12.49%, while the Sensex has only decreased by 2.01%. Despite the recent downturn, the stock has generated a return of 22.82% over the past year, outperforming the Sensex's 1.89% increase, and has consistently delivered strong returns over the last three years. However, the current negative price movement may be attributed to short-term market pressures and declining trading volumes, overshadowing the company's solid long-term performance and attractive valuation metrics.